Back to Network
8
Shared Docs
8
Same-Page
8 / 8
Mentions
Document Mentions (8 shared documents)
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 134.01 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
siness day for this statement period. Please refer to the applicable mutual fund prospectus for further details. If the applicable mutual fund is a JPMorgan Fund, please refer to disclosures on this statement concerning JPMorgan Funds for other important information. Disclosures Page 4 of 4 EFTA01539674
2 mentions1 same-page
Page ?Same page
sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 146.59 09062X-10-3 BIIB 18.06 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP
siness day for this statement period. Please refer to the applicable mutual fund prospectus for further details. If the applicable mutual fund is a JPMorgan Fund, please refer to disclosures on this statement concerning JPMorgan Funds for other important information. Disclosures Page 4 of 4 EFTA01540035
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 130.75 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
siness day for this statement period. Please refer to the applicable mutual fund prospectus for further details. If the applicable mutual fund is a JPMorgan Fund, please refer to disclosures on this statement concerning JPMorgan Funds for other important information. Disclosures Page 4 of 4 EFTA01539755
Sponsored
2 mentions1 same-page
Page ?Same page
sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC DEAN FOODS CO FACEBOOK INC-A 04033A-10-0 ARIA 146.37 09062X-10-3 BIIB 16.51 242370-10-4 DF 26.62 30303M-10-2 FB Total US Large Cap Equity $1
siness day for this statement period. Please refer to the applicable mutual fund prospectus for further details. If the applicable mutual fund is a JPMorgan Fund, please refer to disclosures on this statement concerning JPMorgan Funds for other important information. Disclosures Page 4 of 4 EFTA01540443
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 149.21 09062X-10-3 BIIB 21.66 30303M-10-2 FB Total US Large Cap Equity $1,091,957.30 $1,166,930.47 ($74,973
siness day for this statement period. Please refer to the applicable mutual fund prospectus for further details. If the applicable mutual fund is a JPMorgan Fund, please refer to disclosures on this statement concerning JPMorgan Funds for other important information. Disclosures Page 4 of 4 EFTA01540134
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 126.00 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
siness day for this statement period. Please refer to the applicable mutual fund prospectus for further details. If the applicable mutual fund is a JPMorgan Fund, please refer to disclosures on this statement concerning 3PMorgan Funds for other important information. Disclosures Page 4 of 4 EFTA01539591
Sponsored
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 144.38 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
siness day for this statement period. Please refer to the applicable mutual fund prospectus for further details. If the applicable mutual fund is a JPMorgan Fund, please refer to disclosures on this statement concerning JPMorgan Funds for other important information. Disclosures Page 4 of 4 EFTA01539852
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
siness day for this statement period. Please refer to the applicable mutual fund prospectus for further details. If the applicable mutual fund is a JPMorgan Fund, please refer to disclosures on this statement concerning JPMorgan Funds for other important information. Disclosures Page 4 of 4 EFTA01539937
Sponsored
Mutual Connections (94)
Entities connected to both BIOGEN IDEC INC and JPMorgan Fund
Global Access Portfolios
ORGANIZATION8 w/ BIOGEN·113 w/ JPMorgan
JPMorgan Chase
ORGANIZATION16 w/ BIOGEN·95 w/ JPMorgan
the Internal Revenue Service
ORGANIZATION9 w/ BIOGEN·93 w/ JPMorgan
Securities Investor Protection Corporation
ORGANIZATION9 w/ BIOGEN·84 w/ JPMorgan
Newark
LOCATION9 w/ BIOGEN·81 w/ JPMorgan
Ghislaine Maxwell
PERSON15 w/ BIOGEN·73 w/ JPMorgan
Nassau
LOCATION8 w/ BIOGEN·70 w/ JPMorgan
CITIGROUP CAPITAL XIII
ORGANIZATION8 w/ BIOGEN·52 w/ JPMorgan
Bank of America
ORGANIZATION9 w/ BIOGEN·42 w/ JPMorgan
Paul Barrett
PERSON15 w/ BIOGEN·31 w/ JPMorgan
FDIC
ORGANIZATION15 w/ BIOGEN·28 w/ JPMorgan
JG
Jason Grosse
PERSON3 w/ BIOGEN·38 w/ JPMorgan
Paul Morris
PERSON7 w/ BIOGEN·33 w/ JPMorgan
US Small/Mid Cap Equity
ORGANIZATION9 w/ BIOGEN·28 w/ JPMorgan
GENERAL MOTORS CO
ORGANIZATION11 w/ BIOGEN·23 w/ JPMorgan
Barclays
ORGANIZATION11 w/ BIOGEN·21 w/ JPMorgan
Deutsche Bank
ORGANIZATION15 w/ BIOGEN·13 w/ JPMorgan
GENERAL MOTORS CO CV
ORGANIZATION5 w/ BIOGEN·22 w/ JPMorgan
UNCAPPED
ORGANIZATION12 w/ BIOGEN·15 w/ JPMorgan
FX Fwd Contract
ORGANIZATION11 w/ BIOGEN·12 w/ JPMorgan